The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics

The increased global prevalence of viral and noninfectious liver illnesses has coincided with a surge in scientific interest in gut microbiota (GM), a multispecies community of bacteria, fungi, archaea, and protozoans. Dietary nutrients that make up the host’s microbiome are responsible for maintain...

Full description

Saved in:
Bibliographic Details
Main Authors: K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Advanced Gut & Microbiome Research
Online Access:http://dx.doi.org/10.1155/2023/5431615
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849737262465548288
author K. P. Divya
Parneet Hari
Navjot Kanwar
Navita Aggarwal
Preeti Singh Dhoat
Lu Liu
Abhinav Kanwal
Shailendra Pratap Singh
author_facet K. P. Divya
Parneet Hari
Navjot Kanwar
Navita Aggarwal
Preeti Singh Dhoat
Lu Liu
Abhinav Kanwal
Shailendra Pratap Singh
author_sort K. P. Divya
collection DOAJ
description The increased global prevalence of viral and noninfectious liver illnesses has coincided with a surge in scientific interest in gut microbiota (GM), a multispecies community of bacteria, fungi, archaea, and protozoans. Dietary nutrients that make up the host’s microbiome are responsible for maintaining intestinal homeostasis, whereas a disconnect between gut flora and nutrition might have serious consequences for digestive health. The risk of liver dysfunction was continuously elevated by changes in the commensal bacteria of the gut microbiome, which were carried to the liver via the portal vein. Insights into the role of gut microbiota in alcoholic liver disease, nonalcoholic liver disease, primary sclerosing cholangitis, and other liver disorders, as well as their link to liver cancer, continue to emerge. Systemic host defence against infections by the gut microbiota depends on the interplay between the microbiome, liver immunology, and liver disorders. Translocation of microbiota to the liver following injury and/or inflammation may mediate dysbiosis and the formation of gut microbial metabolite. This review discusses the role of the gut microbiota in connection to dysbiosis and how this knowledge might help us better understand the pathophysiology of various liver illnesses.
format Article
id doaj-art-8420e5a2ed394e02b60127896c04646e
institution DOAJ
issn 2755-1652
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Advanced Gut & Microbiome Research
spelling doaj-art-8420e5a2ed394e02b60127896c04646e2025-08-20T03:06:58ZengWileyAdvanced Gut & Microbiome Research2755-16522023-01-01202310.1155/2023/5431615The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and TherapeuticsK. P. Divya0Parneet Hari1Navjot Kanwar2Navita Aggarwal3Preeti Singh Dhoat4Lu Liu5Abhinav Kanwal6Shailendra Pratap Singh7Manipal College of Pharmaceutical SciencesInternal MedicineUniversity Institute of Pharmaceutical SciencesDepartment of PharmacologyDepartment of PharmacologyEndoscopic Diagnosis and Treatment Center of Baoding First Central HospitalDepartment of PharmacologyDepartment of Sports BiosciencesThe increased global prevalence of viral and noninfectious liver illnesses has coincided with a surge in scientific interest in gut microbiota (GM), a multispecies community of bacteria, fungi, archaea, and protozoans. Dietary nutrients that make up the host’s microbiome are responsible for maintaining intestinal homeostasis, whereas a disconnect between gut flora and nutrition might have serious consequences for digestive health. The risk of liver dysfunction was continuously elevated by changes in the commensal bacteria of the gut microbiome, which were carried to the liver via the portal vein. Insights into the role of gut microbiota in alcoholic liver disease, nonalcoholic liver disease, primary sclerosing cholangitis, and other liver disorders, as well as their link to liver cancer, continue to emerge. Systemic host defence against infections by the gut microbiota depends on the interplay between the microbiome, liver immunology, and liver disorders. Translocation of microbiota to the liver following injury and/or inflammation may mediate dysbiosis and the formation of gut microbial metabolite. This review discusses the role of the gut microbiota in connection to dysbiosis and how this knowledge might help us better understand the pathophysiology of various liver illnesses.http://dx.doi.org/10.1155/2023/5431615
spellingShingle K. P. Divya
Parneet Hari
Navjot Kanwar
Navita Aggarwal
Preeti Singh Dhoat
Lu Liu
Abhinav Kanwal
Shailendra Pratap Singh
The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
Advanced Gut & Microbiome Research
title The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
title_full The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
title_fullStr The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
title_full_unstemmed The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
title_short The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
title_sort role of the gut microbiome and the hepatic axis in the pathogenesis of metabolic syndrome and therapeutics
url http://dx.doi.org/10.1155/2023/5431615
work_keys_str_mv AT kpdivya theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT parneethari theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT navjotkanwar theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT navitaaggarwal theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT preetisinghdhoat theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT luliu theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT abhinavkanwal theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT shailendrapratapsingh theroleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT kpdivya roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT parneethari roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT navjotkanwar roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT navitaaggarwal roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT preetisinghdhoat roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT luliu roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT abhinavkanwal roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics
AT shailendrapratapsingh roleofthegutmicrobiomeandthehepaticaxisinthepathogenesisofmetabolicsyndromeandtherapeutics